Introduction to Cardiac Changes in FGR

Fetal growth restriction (FGR) remains a significant challenge in modern obstetrics. It is often linked to placental insufficiency and chronic hypoxia. Recent research emphasizes that FGR does more than just limit weight; it significantly alters fetal cardiac function. Understanding these subclinical changes is crucial for optimizing perinatal care and predicting long-term health outcomes. A recent systematic review and meta-analysis have provided clear evidence regarding these hemodynamic adaptations.

Geometric and Morphological Alterations

The study found that fetuses affected by FGR exhibit distinct changes in cardiac geometry. Specifically, these fetuses show a smaller right and left sphericity index (SI) compared to those in non-complicated pregnancies. This change indicates a shift toward a more globular heart shape. Furthermore, such remodeling often serves as an early adaptive response to increased afterload and placental resistance. Consequently, clinicians must recognize that structural changes often precede overt clinical deterioration.

Systolic and Diastolic Dysfunction in FGR

While cardiac output might initially remain stable, specific markers of systolic and diastolic performance show significant impairment. Fetuses with FGR typically demonstrate shorter mitral and tricuspid annular plane systolic excursions (MAPSE and TAPSE). These measurements are vital indicators of longitudinal myocardial contraction. Additionally, diastolic function is compromised, as evidenced by reduced mitral and tricuspid E/A ratios. Therefore, monitoring fetal cardiac function through these Doppler parameters provides a more nuanced view of fetal well-being than growth charts alone.

Impact on Global Fetal Cardiac Function

Global cardiac performance is perhaps the most sensitive indicator of fetal distress in growth-restricted pregnancies. The meta-analysis revealed that FGR fetuses have significantly longer isovolumetric contraction times (ICT) and relaxation times (IRT). Most importantly, the Myocardial Performance Index (MPI), which combines these measurements, is significantly elevated. This elevation suggests a combined burden of systolic and diastolic dysfunction. Consequently, these fetuses face a higher risk of perinatal morbidity and may require intensive monitoring.

Clinical Implications and Long-Term Risks

The evidence suggests that cardiac remodeling in utero may have lasting effects. Studies indicate that these children may face an increased risk of hypertension and metabolic syndrome in adulthood. In the Indian context, where the burden of FGR is high, early identification of these cardiac markers could improve risk stratification. Moreover, integrated screening using advanced echocardiography may help in timing deliveries more effectively. Therefore, clinicians should consider these functional parameters when managing high-risk pregnancies.

Frequently Asked Questions

How does FGR impact fetal heart shape?

Fetuses with FGR often develop a more globular heart. This is reflected in a reduced sphericity index for both the left and right ventricles, indicating significant geometric remodeling due to placental resistance.

What are the primary signs of systolic dysfunction in FGR?

The primary indicators include reduced MAPSE and TAPSE values. These markers show that the longitudinal movement of the atrioventricular plane is impaired, even if the overall cardiac output remains within normal limits initially.

Does FGR affect the global performance of the heart?

Yes, FGR leads to an increased Myocardial Performance Index (MPI). This is caused by prolonged isovolumetric contraction and relaxation times, signaling a decrease in overall cardiac efficiency.

Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice. It is not intended to be a substitute for professional medical judgment, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.

References

D'Amico A et al. Cardiac Function in Fetal Growth Restriction: A Systematic Review and Meta-Analysis. Prenat Diagn. 2026 Apr 23. doi: 10.1002/pd.70145. PMID: 42026684.

Crispi F et al. Long-term cardiovascular consequences of fetal growth restriction: biology, clinical implications, and opportunities for prevention of adult disease. Am J Obstet Gynecol. 2018;218(2S):S869-S880.

Van Oostrum N et al. Understanding changes in echocardiographic parameters at different ages following fetal growth restriction: a systematic review and meta-analysis. Am J Physiol Heart Circ Physiol. 2024;326(6):H1450-H1462.